List of works - Daniel Oder

Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study.

scientific article published on 7 February 2018

Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease

scientific article published on 12 July 2018

Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve Stenosis

scientific article published on 11 November 2018

Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease.

scientific article published on 21 November 2017

Case report of a 45-year old female Fabry disease patient carrying two alpha-galactosidase A gene mutation alleles.

scientific article

Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study

scientific article published on 15 December 2016

Characterization of vertigo and hearing loss in patients with Fabry disease

scientific article published on 15 August 2018

Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T: A single-center observational study.

article

Coronary B-cell lymphoma infiltration causing myocardial infarction

scientific article published on 01 March 2020

Die Fabry-Kardiomyopathie als Differenzialdiagnose des akuten Koronarsyndroms

scientific article published on 22 March 2017

Echocardiographic Determinants of One-Year All-Cause Mortality in Patients With Chronic Heart Failure Complicated by Significant Functional Tricuspid Regurgitation

scientific article published on 24 November 2016

Immunosuppressive effect on ERT inhibition in transplanted patients with Fabry disease

scholarly article by Malte Lenders published in January 2017

Letter by Oder et al Regarding Article, "Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-

scientific article published on 01 August 2018

Long Term Treatment with Enzyme Replacement Therapy in Patients with Fabry Disease

scientific article published on 27 August 2016

Lucerastat, an Iminosugar for Substrate Reduction Therapy: Tolerability, Pharmacodynamics, and Pharmacokinetics in Patients With Fabry Disease on Enzyme Replacement.

scientific article published on 12 July 2017

Lucerastat, an iminosugar for substrate reduction therapy: safety, tolerability, pharmacodynamics, and pharmacokinetics in adult subjects with Fabry disease

scholarly article by Nicolas Guérard published in January 2017

Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year

scientific article published on 13 January 2019

Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y.

scientific article published on 8 April 2016

Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors

scientific article published on August 2017

Value of cardiac biomarker measurement in the differential diagnosis of infiltrative cardiomyopathy patients with preserved left ventricular systolic function